The company sources active pharmaceutical ingredients (API) and finished drug products through third-party contractors who undergo a formal qualification process. It has a master services agreement with Evotec A.G. (formerly Aptuit, Oxford) for manufacturing the API mavorixafor. Additionally, the company maintains a master services agreement with Catalent Inc., which serves as the sole manufacturer of the final capsule drug product formulation of mavorixafor. This agreement with Catalent Inc. is set to expire on December 31, 2028, and includes specified termination clauses. The company ensures compliance with current Good Manufacturing Practices (cGMPs) and other global regulations by relying on contract manufacturers for production of compounds used in clinical trials and distribution. This approach enables the company to allocate resources toward development and commercialization rather than manufacturing infrastructure.
X4 Pharmaceuticals Inc's Comment on Supply Chain
The company sources active pharmaceutical ingredients (API) and finished drug products through third-party contractors who undergo a formal qualification process. It has a master services agreement with Evotec A.G. (formerly Aptuit, Oxford) for manufacturing the API mavorixafor. Additionally, the company maintains a master services agreement with Catalent Inc., which serves as the sole manufacturer of the final capsule drug product formulation of mavorixafor. This agreement with Catalent Inc. is set to expire on December 31, 2028, and includes specified termination clauses. The company ensures compliance with current Good Manufacturing Practices (cGMPs) and other global regulations by relying on contract manufacturers for production of compounds used in clinical trials and distribution. This approach enables the company to allocate resources toward development and commercialization rather than manufacturing infrastructure.
Sources:
X4 Pharmaceuticals Inc's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on X4 Pharmaceuticals Inc’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
